A vaccine that appears to slow the progression of one of the most deadly cancers could be manufactured in bulk, researchers say.
The jab has given hope to patients after a trial found it increased the survival of participants with pancreatic cancer.
A vaccine that appears to slow the progression of one of the most deadly cancers could be manufactured in bulk, researchers say.
The jab has given hope to patients after a trial found it increased the survival of participants with pancreatic cancer.